APA (7th ed.) Citation

Dulaijan, B. A., Huang, S., Lin, C. J. F., Denton, C. P., & Khanna, D. Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab in Scleroderma. Wiley.

Chicago Style (17th ed.) Citation

Dulaijan, Basmah Al, Suiyuan Huang, Celia J. F. Lin, Christopher P. Denton, and Dinesh Khanna. Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab in Scleroderma. Wiley.

MLA (9th ed.) Citation

Dulaijan, Basmah Al, et al. Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab in Scleroderma. Wiley.